Page 48 - 80_01

SREBP-­-1c,
ChREBP
y
LXR…

178. Ross,
S.E.,
Erickson,
R.L.,
Gerin,
I.
y
col.
2002.
Microarray
analyses
during

adipogenesis:
understanding
the
effects
of
Wnt
signaling
on
adipogenesis
and
the
roles
of

liver
X
receptor
alpha
in
adipocyte
metabolism.
Mol
Cell
Biol
22,
5989-­-5999.

179. Dalen,
K.T.,
Ulven,
S.M.,
Bamberg,
K.
y
col.
2003.
Expression
of
the
insulin-­-
responsive
glucose
transporter
GLUT4
in
adipocytes
is
dependent
on
liver
X
receptor

alpha.
J
Biol
Chem
278,
48283-­-48291.

180. Gerin,
I.,
Dolinsky,
V.W.,
Shackman,
J.G.
y
col.
2005.
LXRbeta
is
required
for

adipocyte
growth,
glucose
homeostasis,
and
beta
cell
function.
J
Biol
Chem
280,
23024-­-
23031.

181. Pettersson,
A.M.,
Stenson,
B.M.,
Lorente-­-Cebrián,
S.
y
col.
2013.
LXR
is
a
negative

regulator
of
glucose
uptake
in
human
adipocytes.
Diabetologia
56,
2044-­-2054.

182. Zitzer,
H.,
Wente,
W.,
Brenner,
M.B.
y
col.
2006.
Sterol
regulatory
element-­-binding

protein
1
mediates
liver
X
receptor-­-beta-­-induced
increases
in
insulin
secretion
and
insulin

messenger
ribonucleic
acid
levels.
Endocrinology
147,
3898-­-3905.

183. Choe,
S.S.,
Choi,
A.H.,
Lee,
J.W.
y
col.
2007.
Chronic
activation
of
liver
X
receptor

induces
beta-­-cell
apoptosis
through
hyperactivation
of
lipogenesis:
liver
X
receptor-­-
mediated
lipotoxicity
in
pancreatic
beta-­-cells.
Diabetes
56,
1534-­-1543.

184. López,
J.M.,
Bennett,
M.K.,
Sanchez,
H.B.
y
col.
1996.
Sterol
regulation
of
acetyl

coenzyme
A
carboxylase:
a
mechanism
for
coordinate
control
of
cellular
lipid.
Proc
Natl

Acad
Sci
U
S
A
93,
1049-­-1053.

185. Tabor,
D.E.,
Kim,
J.B.,
Spiegelman,
B.M.,
Edwards,
P.A.,
1998.
Transcriptional

activation
of
the
stearoyl-­-CoA
desaturase
2
gene
by
sterol
regulatory
element-­-binding

protein/adipocyte
determination
and
differentiation
factor
1.
J
Biol
Chem
273,
22052-­-
22058.

186. Joseph,
S.B.,
Laffitte,
B.A.,
Patel,
P.H.
y
col.
2002.
Direct
and
indirect
mechanisms

for
regulation
of
fatty
acid
synthase
gene
expression
by
liver
X
receptors.
J
Biol
Chem
277,

11019-­-11025.

187. Chisholm,
J.W.,
Hong,
J.,
Mills,
S.A.,
Lawn,
R.M.,
2003.
The
LXR
ligand
T0901317

induces
severe
lipogenesis
in
the
db/db
diabetic
mouse.
J
Lipid
Res
44,
2039-­-2048.

188.
Grefhorst,
A.,
Elzinga,
B.M.,
Voshol,
P.J.
y
col.
2002.
Stimulation
of
lipogenesis
by

pharmacological
activation
of
the
liver
X
receptor
leads
to
production
of
large,

triglyceride-­-rich
very
low
density
lipoprotein
particles.
J
Biol
Chem
277,
34182-­-34190.

189. Ducheix,
S.,
Montagner,
A.,
Polizzi,
A.
y
col.
2013.
Essential
fatty
acids
deficiency

promotes
lipogenic
gene
expression
and
hepatic
steatosis
through
the
liver
X
receptor.
J

Hepatol
58,
984-­-992.

190. Patel,
R.,
Patel,
M.,
Tsai,
R.
y
col.
2011.
LXRß
is
required
for
glucocorticoid-­-induced

hyperglycemia
and
hepatosteatosis
in
mice.
J
Clin
Invest
121,
431-­-441.

191. Ducheix,
S.,
Montagner,
A.,
Theodorou,
V.
y
col.
2013.
The
liver
X
receptor:
a

master
regulator
of
the
gut-­-liver
axis
and
a
target
for
non
alcoholic
fatty
liver
disease.

Biochem
Pharmacol
86,
96-­-105.

192. Higuchi,
N.,
Kato,
M.,
Shundo,
Y.
y
col.
2008.
Liver
X
receptor
in
cooperation
with

SREBP-­-1c
is
a
major
lipid
synthesis
regulator
in
nonalcoholic
fatty
liver
disease.
Hepatol

Res
38,
1122-­-1129.

193. Zelcer,
N.,
Tontonoz,
P.,
2006.
Liver
X
receptors
as
integrators
of
metabolic
and

inflammatory
signaling.
J
Clin
Invest
116,
607-­-614.

194. Hong,
C.,
Tontonoz,
P.,
2008.
Coordination
of
inflammation
and
metabolism
by

PPAR
and
LXR
nuclear
receptors.
Curr
Opin
Genet
Dev
18,
461-­-467.

195. Jakobsson,
T.,
Treuter,
E.,
Gustafsson,
J.,
Steffensen,
K.R.,
2012.
Liver
X
receptor

biology
and
pharmacology:
new
pathways,
challenges
and
opportunities.
Trends

Pharmacol
Sci
33,
394-­-404.

196. Wang,
Y.Y.,
Dahle,
M.K.,
Agren,
J.
y
col.
2006.
Activation
of
the
liver
X
receptor

protects
against
hepatic
injury
in
endotoxemia
by
suppressing
Kupffer
cell
activation.

Shock
25,
141-­-146.

197. Mallat,
A.,
Lotersztajn,
S.,
2011.
The
liver
X
receptor
in
hepatic
stellate
cells:
a

novel
antifibrogenic
target?
J
Hepatol
55,
1452-­-1454.

198. Beaven,
S.W.,
Wroblewski,
K.,
Wang,
J.
y
col.
2011.
Liver
X
receptor
signaling
is
a

determinant
of
stellate
cell
activation
and
susceptibility
to
fibrotic
liver
disease.

Gastroenterology
140,
1052-­-1062.

47